Matthew Singleton Net Worth & Insider Trades
Matthew Singleton - Director, Viking Therapeutics, Inc
What is Matthew Singleton's Net Worth?
The current estimated net worth of Viking Therapeutics, Inc's Director, Matthew Singleton, is estimated to be about $23.99K . Matthew Singleton owns about 9,500 units of Viking Therapeutics, Inc common stock. In the last 8 years at Viking Therapeutics, Inc, Matthew Singleton has sold an estimated value of $0 worth.
What is Matthew Singleton's Past Insider Trading?
Matthew Singleton's largest purchase order was 9,500 units , worth over $93.26K on May 31, 2018. In total, Matthew Singleton has made about 10 transactions over 8 years of their time at Viking Therapeutics, Inc. Matthew Singleton usually trades in January, with the busiest year in 2018.
MATTHEW SINGLETON
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What is Matthew Singleton's' Mailing Address?
- Mailing address is 286 Stanwich Road Greenwich CT 06830 CT
Viking Therapeutics, Inc Executive Compensation
Name |
Year
|
Salary
|
Other Earnings Plans or Compensations
|
Stock Awards
|
Option Awards
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|
| Brian Lian, Ph.D. | 2020 | $577,000 | $301,000 | $2,485,102 | $1,824,346 | - | $5,187,448 |
| Brian Lian, Ph.D. | 2019 | $525,000 | $210,000 | $1,530,379 | $1,246,740 | - | $3,512,119 |
| No matching records found | |||||||
Source: https://www.sec.gov/Archives/edgar/data/1607678/000156459021018175/vktx-def14a_20210520.htm
What are Viking Therapeutics, Inc's Past Insider Trades?
Viking Therapeutics, Inc's most recent insider trade came on May 3, 2022 by Matthew Foehr who bought 45,000 units worth $111.19K . In the last 7 years, insiders at Viking Therapeutics, Inc have sold an estimated value of $10.48M and bought an estimated value of $2.49M worth of shares. Insider trading is most common in January, with the busiest year in 2021. The most active traders at the company are Michael Morneau, VP, Brian Lian, President & CEO, and Matthew Foehr, Director .
Viking Therapeutics, Inc. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||